Cargando…
LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn's Disease
AIM: To explore the expression of long noncoding RNA (LncRNA) LUCAT1 in adult patients with Crohn's disease (CD) and evaluate the relationship between LncRNA LUCAT1 and the disease activity in Chinese patients with CD. METHODS: Patients with CD and healthy participants (≥18 years old) were enro...
Autores principales: | Kuai, Xiao-yi, Yu, Shun-ying, Cui, Xiu-fang, Zhao, Xiao-jing, Mao, Xia-qiong, Yu, Yang, Hu, Tong, Zhang, Hong-jie, Zhou, Chun-li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492250/ https://www.ncbi.nlm.nih.gov/pubmed/34621310 http://dx.doi.org/10.1155/2021/5557357 |
Ejemplares similares
-
LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer
por: Luzón-Toro, B., et al.
Publicado: (2019) -
The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2
por: Vierbuchen, Tim, et al.
Publicado: (2022) -
Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p
por: Yang, Ting, et al.
Publicado: (2020) -
LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702
por: Mou, Exian, et al.
Publicado: (2019) -
Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway
por: Jin, Tingting, et al.
Publicado: (2020)